![Abbie Celniker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abbie Celniker
Président chez
Rheos Medicines, Inc.
Profil
Abbie C.
Celniker is Chairman at Rheos Medicines, Inc. since 2019, Chairman at Cedilla Therapeutics, Inc. since 2018, Chairman at Abata Therapeutics, Inc., Director at Massachusetts Biotechnology Council, Director at T1D Exchange, Director at Unitio, Inc., Director at Flare Therapeutics, Inc., and Partner at Third Rock Ventures LLC since 2016.
Former roles include President, Chief Executive Officer & Director at Taligen Therapeutics, Inc. from 2010, CEO at Sesen Bio, Inc. from 2016 to 2018, Chairman at ImaginAb, Inc. from 2012 to 2016, Associate Director-Biological Assay Development at Genentech, Inc., Director at Dyax Corp.
from 2015 to 2016, Director at Massachusetts Life Sciences Center, Director at Goldfinch Bio, Inc., SVP-Operations, Research & Development Strategy at Millennium Pharmaceuticals, Inc., Executive Vice President-Translational Medicine at Alexion Pharmaceuticals, Inc. in 2011, Head-Biologics at Novartis AG, Principal at Wyeth BioPharma, Vice President-Protein Technologies at Wyeth Research, and President-Wyeth Research at Protein Technologies, Inc. Education includes an undergraduate degree from the University of California San Diego in 1980 and a doctorate from the University of Arizona College of Medicine in 1986.
Postes actifs de Abbie Celniker
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Membre du Conseil | - |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01/06/2016 |
T1D Exchange
 T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Directeur/Membre du Conseil | - |
Unitio, Inc.
 Unitio, Inc. Internet Software/ServicesTechnology Services Operates a platform for health care industry | Directeur/Membre du Conseil | - |
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Président | 06/09/2018 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Président | 01/03/2018 |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Président | - |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur/Membre du Conseil | - |
Anciens postes connus de Abbie Celniker
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur Général | 21/09/2016 |
| ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Abbie Celniker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Wyeth BioPharma
 Wyeth BioPharma Pharmaceuticals: MajorHealth Technology Develops and manufactures protein biopharmaceuticals | Health Technology |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Protein Technologies, Inc.
 Protein Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures peptide synthesizers and reagents | Health Technology |
Massachusetts Life Sciences Center
 Massachusetts Life Sciences Center Investment ManagersFinance Functions as a Pension/Retirement Fund | Finance |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology Develops radiopharmaceutical and imaging agent products | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Health Technology |
University of Arizona College of Medicine
 University of Arizona College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
Unitio, Inc.
Unitio, Inc. Internet Software/ServicesTechnology Services Operates a platform for health care industry | Technology Services |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Health Technology |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
